4 Results for "

ATM-deficient cancer cells

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "ATM-deficient cancer cells" in MCE Product Catalog:

Cat. No.: HY-157764
CAS No.: 2925916-30-7
Research Areas:  

Cancer

PROTAC ATR degrader-1 is a ATR PROTAC degrader. PROTAC ATR degrader-1 promotes ubiquitination and degradation of ATR. PROTAC ATR degrader-1 facilitates the progression of cells through the G2/M phase, thereby impairing DNA repair and inducing Apoptosis. PROTAC ATR degrader-1 exerts anticancer effects against colorectal cancer either alone or in combination with Cisplatin (HY-17394). PROTAC ATR degrader-1 can be used in research related to colorectal cancer .
loading...
    loading...
Cat. No.: HY-184294
CAS No.: 3037598-39-0
Research Areas:  

Cancer

ZH25 is an ATR kinase inhibitor with antiproliferative activity against ATM-deficient cancer cells. ZH25 induces DNA damage, reduces G2/M phase cell proportion, upregulates γH2AX, Cleaved-Caspase3, and Cleaved-PARP. ZH25 functions as an ATR kinase binding ligand for ATR-PROTAC degrader design. ZH25 can be used for the research of atm-deficient cancer .
loading...
    loading...
Cat. No.: HY-184293
Target:  

PROTACs ATM/ATR Apoptosis

Research Areas:  

Cancer

PROTAC ATR degrader-4 is a PROTAC-based ATR kinase degrader, with a DC50 of 6.18 μM and a Dmax of 71.42% in LoVo cells. PROTAC ATR degrader-4 downregulates ATR protein expression, inducing nuclear envelope rupture, genomic instability, DNA damage and apoptosis. PROTAC ATR degrader-4 exhibits anti-tumor activity in xenograft tumor mouse models and can be used for the research of atm-deficient cancers .
loading...
    loading...
Cat. No.: HY-182018
CAS No.: 3126270-19-4
Research Areas:  

Others

ATR ligand 2-CO-Ph-COOH (Compound 39) is a Target Protein Ligand-Linker Conjugate that incorporates a ligand for ATR (HY-182017) and a PROTAC linker, which recruits E3 ligases. can be used for synthesis of PROTAC ATR degrader-3 (HY-182016) .
loading...
    loading...